Up next

Autoplay

Promising Emerging Classes of Therapies in Non-Small Cell Lung Cancer

14 Views • 07/14/23
Share
Embed
administrator
administrator
Subscribers
0

David Gandara, MD, Corey J. Langer, MD, Anne S. Tsao, MD, Alan B. Sandler, MD, and Mark A. Socinski, MD, each provide their opinion on the most promising emerging class of therapeutics in non-small cell lung cancer (NSCLC).

More from this Peer Exchange discussion: http://www.onclive.com/peer-ex....change/nsclc-advance

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay